Delivery Order SPE2DB20D9332-SPE2DB25FV3B9
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,424.44 by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of XOLAIR 150 mg/ml autoinjector medication. The contract carries a firm fixed-price structure with an ultimate completion date of August 28, 2025, and was awarded without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $1,712.23 by the Defense Logistics Agency (DLA) for the supply of Xolair 300 mg/2 ml auto-injector vials. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Xolair 300 mg/2 mL auto-injector vials valued at $3,424.46. The award, issued on September 3, 2025, with a completion date of September 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will perform the delivery at its location. This delivery order falls...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,712.23 by the Defense Logistics Agency on August 15, 2025. The contract calls for delivery of Xolair 300 mg/2 mL auto-injector vials, a prescription medication used in the treatment of moderate-to-severe allergic asthma and chronic idiopathic urticaria. The delivery order carries an ultimate completion date of September 8,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,273.38 by the Defense Logistics Agency on August 15, 2025, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, carries no set-aside designation. The award represents a discrete fulfillment order issued under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $1,712.22 by the Defense Logistics Agency for Xolair 150 mg/mL autoinjectors. This firm fixed-price delivery order, awarded on September 12, 2025, is expected to be completed by October 3, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,424.46 by the Defense Logistics Agency on August 19, 2025. The contract calls for the delivery of Xolair 300 mg/2 ml auto-injector vials, a biologic medication used primarily for severe asthma and other allergic conditions. This delivery order was issued without a set-aside designation, and performance is scheduled for...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,848.88 by the Defense Logistics Agency (DLA) on September 3, 2025. The contract calls for the delivery of Xolair 150 mg/ml auto-injector medication, with an ultimate completion date of September 24, 2025. No set-aside designation was applied to this award. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, issued on September 3, 2025, with completion targeted for September 24, 2025, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on September 9, 2025, for the supply of Xolair 300 mg/2 ml auto-injector vials. The contract has a ceiling value of $6,848.92 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. No set-aside designation was applied to this award, and performance will take place...
- SPE2DB20D9332Indefinite Delivery Contract
- SPE2DB20D9332-SPE2DB25FV3B9Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,424.46 by the Defense Logistics Agency on September 11, 2025, for the supply of Xolair 300 mg/2 mL auto-injector units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, and no set-aside designation was applied to this procurement action. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across military health facilities worldwide. As a crucial supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated consistent success in competing for Defense Logistics Agency contracts across diverse product categories including prescription medications, biologics, auto-injectors, and specialty pharmaceutical items. The company's portfolio of federal awards reflects its central role in providing direct distribution of pharmaceutical products and pharmacy services to Department of Defense healthcare sites, with this particular delivery order for Xolair—a biologic medication used in the treatment of allergic asthma and other conditions—representing a routine fulfillment of the broader indefinite delivery contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/11/25 |